Icosavax, Inc.
ICVXDelisted Feb 20, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001786255
Icosavax, Inc. was delisted on Feb 20, 2024; its insiders filed their last Form 4 on Feb 20, 2024; 93 institutions reported holding it in 13F filings for Q4 2023, worth $663.0M in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Icosavax, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 57 | 73 | +16 |
| Shares | 32.9M | 32.1M | −742.7K (−2.3%) |
| Value | $188.3M | $101.5M | −$86.8M (−46.1%) |
New holders (21)
Institutions that held Icosavax, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (5)
Institutions that held Icosavax, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Price T Rowe Associates Inc | 3,342,470 | $19.2M |
| Janus Henderson Group PLC | 632,598 | $3.63M |
| Dynamic Technology Lab Private Ltd | 10,868 | $62.0K |
| Ensign Peak Advisors, Inc | 5,760 | $33.0K |
| High Net Worth Advisory Group LLC | 500 | $3.00K |